Comparison of Electroencephalogram between remimazolam and propofol under general anesthesia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0007247

Enrollment

Registered

2022-04-29

Start date

2022-05-02

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : * Remimazolam use groups: Anesthesia induction 12mg/kg/hr , Anesthesia maintenance: 1mg~2mg/kg/hr * Propofol use groups: Induction of anesthesia: Enter the patient's height, age, and gender

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients aged between 20 and 70 years of age 2) Patients undergoing general anesthesia with total intravenous anesthesia 3) Patients who agreed to the clinical study among patients who fall into ASA class 1, 2, 3, and 4 of the American Society of Anesthesiology

Exclusion criteria

Exclusion criteria: 1) Patients who do not agree to the clinical study 2) Women of childbearing age 3) Patients with a specific history of grade 5 or higher in the American Society of Anesthesiology Body Classification (ASA class)

Design outcomes

Primary

Measure	Time frame
Electroencephalogram	—

Secondary

Measure	Time frame
vital sign ;Total amount of drug used	—

Countries

Korea, Republic of

Contacts

Public ContactJiho Park

CHUNGNAM NATIONAL UNIVERSITY SEJONG HOSPITAL

jihopark@cnuh.co.kr+82-44-995-3927

Outcome results